Compliance - certificate under Reg. 74(5) of SEBI (DP) Regulations 2018
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Vista Pharmaceuticals Ltd. on 6ix
Earlier from Vista Pharmaceuticals
- Vista Pharmaceuticals Ltd. Press Release Sep 30 2025
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- Shareholder Meeting / Postal Ballot-Outcome of AGM
- Vista Pharmaceuticals Ltd. Press Release Sep 25 2025
- Closure of Trading Window
Later from Vista Pharmaceuticals
- Board Meeting Intimation for 1. Unaudited Financial Results For The Quarter Ended 30.09.2025.2. Limited Review Report For Quarter Ended 30.09.2025.3. Any Other Business With The Permission Of The Chair.
- Vista Pharmaceuticals Ltd. Press Release Nov 04 2025
- Vista Pharmaceuticals Ltd. Press Release Jan 13 2026
- Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - 'Joint Venture Partnership Between Pleiades Therapeutics And Vista Pharmaceuticals Ltd'
- Vista Pharmaceuticals Ltd. Press Release Feb 03 2026
Follow Vista Pharmaceuticals into a list and get an email when it puts out news.
Follow Vista Pharmaceuticals